Generated by GPT-5-mini| European Respiratory Society | |
|---|---|
| Name | European Respiratory Society |
| Founded | 1990 |
| Headquarters | Geneva, Switzerland |
| Fields | Respiratory medicine |
European Respiratory Society is an international professional association focused on respiratory medicine, clinical pulmonology, and lung science. It brings together clinicians, researchers, allied health professionals, and policy stakeholders from across Germany, France, United Kingdom, Italy, and other European and global institutions. The Society engages with academic centres such as University of Oxford, Karolinska Institutet, University of Paris, Heidelberg University, and University of Barcelona and collaborates with organizations including World Health Organization, European Commission, European Centre for Disease Prevention and Control, Lung Foundation Australia, and American Thoracic Society.
Founded in 1990, the Society emerged during a period marked by developments following the World Health Organization respiratory initiatives, the expansion of the European Union and the transformation of biomedical networks across Eastern Europe. Early leadership included clinicians from institutions like Royal Brompton Hospital, Hôpital Cochin, Charité – Universitätsmedizin Berlin, and Sahlgrenska University Hospital. The Society’s formation paralleled milestones such as the publication of major guidelines from Global Initiative for Chronic Obstructive Lung Disease, collaborations with European Respiratory Journal editors, and responses to public health challenges including the 2003 European heat wave and later the COVID-19 pandemic in Europe.
Governance is structured around an elected Executive Committee, assemblies, and specialist task forces drawing members from universities and hospitals such as University College London, Erasmus University Rotterdam, University of Helsinki, and Trinity College Dublin. Advisory boards feature experts connected to institutions like Imperial College London, Mayo Clinic, and Johns Hopkins University while regulatory engagement includes liaison with European Parliament committees and agencies like the European Medicines Agency. Annual governance cycles include elections, policy committees, and collaborations with professional networks such as European Lung Foundation and national societies like Deutsche Gesellschaft für Pneumologie and Société de Pneumologie de Langue Française.
Membership spans clinicians, researchers, and allied professionals affiliated with centres such as Addenbrooke's Hospital, Hôpital Necker-Enfants Malades, Fondazione Policlinico Universitario Agostino Gemelli, and research institutes including CNRS and Max Planck Society. The Society supports trainee networks linked to European Respiratory School programmes and collaborates with specialty groups at Royal College of Physicians, European Respiratory Journal editorial boards, and patient advocacy entities like European Lung Foundation. Regional representation includes delegates from Poland, Spain, Portugal, Sweden, Norway, Greece, and Hungary.
Scientific output includes journals, task force reports, and guideline documents published in collaboration with editorial teams from European Respiratory Journal, and contributions from researchers at Pasteur Institute, Instituto de Salud Carlos III, University of Amsterdam, and University of Copenhagen. The Society sponsors multicentre trials and registries linked to networks such as ERJ Open Research, cooperative initiatives with ClinicalTrials.gov registries, and consensus statements developed with partners like American Thoracic Society and Asian Pacific Society of Respirology. Working groups address disease areas associated with COPD, asthma, pulmonary fibrosis, pulmonary hypertension, and infectious threats exemplified by SARS-CoV-2 research.
Training programmes include postgraduate courses, fellowship exchanges with centres like Hospital Clínic de Barcelona, simulation workshops at Karolinska University Hospital, and e-learning modules co-developed with institutions such as University of Edinburgh and KU Leuven. Certification and continuous professional development activities reference guidelines from European Board of Respiratory Medicine, collaborations with national training bodies like General Medical Council, and partnerships with patient education programmes run by European Lung Foundation.
The Society convenes an annual international congress that attracts delegates from United States, Canada, China, Japan, Australia, and across Europe and features sessions chaired by faculty from Mayo Clinic, Massachusetts General Hospital, Institut Pasteur, and Charité – Universitätsmedizin Berlin. The congress hosts symposia, poster sessions, and industry exhibitions involving pharmaceutical and device partners subject to interactions with regulatory frameworks from European Medicines Agency. Regional conferences and satellite meetings take place in cities including London, Paris, Munich, Madrid, and Rome.
Advocacy addresses air quality, tobacco control, occupational exposures, and pandemic preparedness, engaging with policy bodies such as the European Commission, World Health Organization Regional Office for Europe, and national ministries of health in Germany and France. Initiatives include guideline dissemination, position statements on emissions intersecting with directives from the European Environment Agency, and collaborations with patient groups like European Lung Foundation to influence frameworks related to Clean Air Act-style policies in European contexts and to respond to emergencies such as the COVID-19 pandemic in Europe.
Category:Medical associations Category:Pulmonology